Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Pancreatic Neoplasms 2Gastrointestinal Neoplasms 2Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Melanoma 1Hepatoblastoma 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

aflibercept 2Radiotherapy 2Psychiatric Rehabilitation 2Leucovorin 2Ipilimumab 2Imatinib Mesylate 2Fluorouracil 2Doxorubicin 2Dasatinib 2Capecitabine 2CTLA-4 Antigen 2venetoclax 1vactosertib 1trametinib 1tanespimycin 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1nilotinib 1neratinib 1motexafin gadolinium 1lorlatinib 1lenvatinib 1ixabepilone 1idelalisib 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × MLN 8237 × Gastrointestinal × Clear all
NCT01154816 2020-05-13

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Children's Oncology Group

Phase 2 Completed
118 enrolled 24 charts
CNSGastrointestinalLymphoidOther hematologic neoplasmSarcoma

Neuroblastoma, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡